Navigation Links
Nick Pace Named EVP -- Operations, Compliance, and Regulatory
Date:3/25/2013

RICHMOND, Va., March 25, 2013 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.) has named Nicholas J. Pace , former executive vice president with Amerigroup as Executive Vice President of Operations, Compliance and Regulatory at the growing health management and advanced testing company.

"The healthcare and biotechnology industries are well-known for their operational, compliance, and regulatory complexities, and Nick is similarly well-known for his capabilities in helping companies operate effectively and excel within this environment," said Tonya Mallory , CEO, President, and Co-founder of HDL, Inc. "We look forward to having Nick on our growing team of healthcare and business leaders."

Most recently, Pace served as executive vice president, general counsel and secretary of Amerigroup, a multi-state publicly traded managed care organization focused on publicly sponsored health programs. Prior to joining Amerigroup in 2006, Pace served as assistant general counsel of CarMax, Inc., the publicly traded auto retailer based in Goochland County, and earlier in his career practiced corporate law at a firm in Silicon Valley. Prior to practicing law, the cum laude graduate of the University of Richmond T.C. Williams School of Law served as a consultant in Ernst & Young's tax group. Pace also holds a master's degree in business administration from the E. Claiborne Robins School of Business at U of R.

"I sincerely appreciate the opportunity to join such a fast-growing company that is having a remarkably positive impact on health outcomes for thousands of Americans. I look forward to helping the company continue its successful growth and expand its offerings that allow for the delivery of more efficient and cost-effective care," Pace said.

About Health Diagnostic Laboratory, Inc.

Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular disease, diabetes, and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Clinical Health Consultants at no additional cost, improving compliance and enhancing satisfaction. For more information about HDL, Inc., visit www.hdlabinc.com.


'/>"/>
SOURCE HDL, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Best Healthcare Websites of 2013 to be Named by Web Marketing Association in 17th Annual WebAward Competition
2. Deacom Named a Finalist for 2013 SmartCEO Voltage Awards
3. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
4. Steven Ek Named President and CEO of Arthrosurface
5. Henry Schein Named to FORTUNEs List of Most Admired Companies for 12th Consecutive Year
6. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
7. TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm
8. Prime Therapeutics named a 2013 National Top Workplace
9. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
10. Cohera Medical Named Winner of 2013 Carnegie Science Award
11. PharmaNet/i3 Renamed inVentiv Health Clinical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):